Market Research Reports and Industry Reports

Dova Pharmaceuticals Inc (DOVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The companys lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist, is under development for the treatment of thrombocytopenia in patients suffering from chronic liver disease. AVA stimulates platelet production and limits platelet transfusion-associated risks including infections, immune reactions and refractories. As AVA is in a tablet form, the patient can take it at home without the need to visit the infusion center. The compound has recently completed two pivotal Phase III clinical trials. Dova is headquartered in Charlottesville, Virginia, the US.

Dova Pharmaceuticals Inc (DOVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Dova Pharma Raises USD10 Million in Venture Financing 10
Equity Offering 11
Dova Pharma Raises USD75 Million in IPO 11
Dova Pharma Raises USD0.2 Million in Private Placement of Units 13
Acquisition 14
Perceptive Advisor Acquires 6.8% Stake in Dova Pharma 14
Dova Pharma Acquires AkaRx from Eisai 15
Dova Pharmaceuticals Inc - Key Competitors 16
Dova Pharmaceuticals Inc - Key Employees 17
Dova Pharmaceuticals Inc - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 09, 2017: Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results 19
Aug 10, 2017: Dova Pharmaceuticals Reports Second Quarter 2017 Operating and Financial Results 20
Corporate Communications 21
Jan 06, 2017: Dova Pharmaceuticals Announces Hiring of CEO and Presentation at the 35th Annual J.P. Morgan Healthcare Conference 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables

List of Tables
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dova Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Dova Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Dova Pharma Raises USD10 Million in Venture Financing 10
Dova Pharma Raises USD75 Million in IPO 11
Dova Pharma Raises USD0.2 Million in Private Placement of Units 13
Perceptive Advisor Acquires 6.8% Stake in Dova Pharma 14
Dova Pharma Acquires AkaRx from Eisai 15
Dova Pharmaceuticals Inc, Key Competitors 16
Dova Pharmaceuticals Inc, Key Employees 17
Dova Pharmaceuticals Inc, Subsidiaries 18

Dova Pharmaceuticals Inc (DOVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The companys lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist,

USD 250View Report

China Endovascular Stent Graft Market Research Report 2017

The global Endovascular Stent Graft market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a

USD 3400View Report

X4 Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

X4 Pharmaceuticals Inc (X4 Pharma) is a clinical stage biotechnology company that develops novel therapeutics to treat cancer and rare diseases. The companys lead drug candidate, X4P-001-LD, is in Phase

USD 250View Report

Supreme Pharmaceuticals Inc (SL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Supreme Pharmaceuticals Inc (Supreme Pharmaceuticals), formerly Supreme Resources Ltd is a medial products production and distributing company. The companys products include medical marijuana, sun grown marijuana and others. It offers

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :22
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube